FPWM
AZN icon

FSB Premier Wealth Management’s AstraZeneca AZN Stock Holding History

FSB Premier Wealth Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$272K Buy
1,437
+245
+21% +$46.1K 0.08% 219
2026
Q1 		$235K Buy
+1,192
New +$230K 0.07% 229

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

FSB Premier Wealth Management's AZN Position: Q2 2026 in Review

FSB Premier Wealth Management increased its AstraZeneca (AZN) stake by 21% in Q2 2026, buying an estimated $46.1K and bringing the position to 1,437 shares worth $272K. The position accounts for 0.08% of the portfolio, ranked #219.

FSB Premier Wealth Management first reported a position in AZN in Q1 2026 and has held it in 2 quarters since. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • FSB Premier Wealth Management held 1,437 shares of AstraZeneca worth $272K as of Q2 2026.
  • FSB Premier Wealth Management bought 245 AstraZeneca shares in Q2 2026, an estimated $46.1K.
  • AstraZeneca made up 0.08% of FSB Premier Wealth Management's portfolio in Q2 2026, its #219 holding.
  • FSB Premier Wealth Management first reported a position in AstraZeneca in Q1 2026 and has held it in 2 quarters since.
  • 1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on FSB Premier Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.